"neuroendocrine tumors" trang 5 - tải miễn phí từ tailieunhanh
Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms

Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms
13    32    1
Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice

Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice
11    30    1
Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm

Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm
12    26    1
The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population

The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population
7    33    1
Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors

Tumor growth rate as a metric of progression, response, and prognosis in pancreatic and intestinal neuroendocrine tumors
9    36    1
Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection

Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection
9    50    1
Delays and routes to diagnosis of neuroendocrine tumours

Delays and routes to diagnosis of neuroendocrine tumours
8    33    1
Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary paget disease, successfully treated with modified FOLFOX6: A case report

Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary paget disease, successfully treated with modified FOLFOX6: A case report
6    31    1
Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC)

Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC)
13    86    1
Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: A retrospective clinical study

Primary neuroendocrine breast carcinomas are associated with poor local control despite favourable biological profile: A retrospective clinical study
7    62    1
Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?

Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
10    71    1
Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: Results of a Delphi questionnaire panel from the NETPraxis program

Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: Results of a Delphi questionnaire panel from the NETPraxis program
11    37    1
Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors
7    26    1
Nomogram for individually predicting overall survival in rectal neuroendocrine tumours

Nomogram for individually predicting overall survival in rectal neuroendocrine tumours
7    38    1
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: A retrospective cross-sectional analysis
11    77    1
Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN

Lung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN
10    27    1
The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea

The clinical features and treatment modality of esophageal neuroendocrine tumors: A multicenter study in Korea
7    30    1
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: The xelbevoct study
10    37    1
Invasive neuroendocrine carcinoma of the breast: A population-based study from the surveillance, epidemiology and end results (SEER) database

Invasive neuroendocrine carcinoma of the breast: A population-based study from the surveillance, epidemiology and end results (SEER) database
10    40    1
World Health Organization grading classification for pancreatic neuroendocrine neoplasms: A comprehensive analysis from a large Chinese institution

World Health Organization grading classification for pancreatic neuroendocrine neoplasms: A comprehensive analysis from a large Chinese institution
11    47    1